ArticleCureus2025
Salivary Titanium Level as a Non-invasive Biomarker for Peri-Implantitis: A Prospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Titanium Degradation Products from Dental Implants: Mechanisms of Release, Biodistribution, and Analytical Detection in Biological Matrices.International journal of molecular sciences · 2026Review
- Comparison of salivary caspase-3 biomarker in peri-implantitis among type 2 diabetic patients.Bioinformation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDental implants are widely used for tooth replacement owing to their biocompatibility and long-term stability. Titanium released from implants into surrounding tissues and saliva may reflect corrosion and disease activity. This study aimed to evaluate salivary titanium ion levels in patients with healthy implants versus those with peri-implantitis one year after implant placement, and to assess their relationship with clinical parameters of peri-implant health. MATERIALS AND
methodsA prospective cohort study was conducted in 30 patients who received single titanium implants in the posterior region in the Department of Oral Pathology at Jawahar Medical Foundation's Annasaheb Chudaman Patil Memorial Dental College, Dhule, Maharashtra, India, from November 2022 to November 2023. Patients were divided into three groups (n = 10 each): no implant (control), healthy peri-implant mucosa, and peri-implantitis diagnosed using standardized clinical and radiographic criteria. Unstimulated whole saliva was collected at the 12-month follow-up using a standardized kit. The titanium concentration of the samples was analyzed using inductively coupled plasma mass spectrometry (ICP-MS). Clinical parameters, including probing depth and marginal bone loss, were recorded at six sites per implant. Data were compared between the groups using appropriate statistical tests.
resultsSalivary titanium levels were lowest in the no-implant group (3.3 ± 1.49 µg/L), significantly higher in patients with healthy implants (127 ± 13.32 µg/L), and highest in the peri-implantitis group (235.3 ± 17.94 µg/L). Probing depth and marginal bone loss followed a similar pattern, increasing from the control (0.21 ± 0.04 mm and 0.29 ± 0.07 mm) to healthy implant (3.14 ± 0.48 mm and 0.77 ± 0.13 mm) and peri-implantitis groups (4.87 ± 0.55 mm and 1.49 ± 0.23 mm). Statistical analysis confirmed significant differences in titanium levels, probing depth, and marginal bone loss across the groups (p = 0.001 for all). Post-hoc tests showed that peri-implantitis was associated with markedly greater values in all measured parameters compared with healthy implants and controls (p = 0.001 for all pairwise comparisons).
conclusionSalivary titanium ion concentration increased with the severity of peri-implant disease and correlated with the clinical indicators of inflammation and bone resorption. This non-invasive biomarker reflects implant surface degradation and may serve as an early diagnostic tool for peri-implantitis. Regular monitoring of salivary titanium could enhance risk assessment and support timely clinical intervention, thereby improving long-term implant outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.